diabetes

Creators of the diabetes toolkit included, from left, Charis Health Center’s Carolyn Moore and Lauren Smith and VUMC’s Lindsay Miller, Lucy Leon, Bianca Sarr, Hannah Beddoe, Autumn Montgomery and Kimberly Burkeen.

Nurses collaborate to create Diabetes Education Toolkit

Vanderbilt recently collaborated with Charis Health Center in Wilson County to create a Diabetes Education Toolkit to better serve Charis’ patient population.

Study sheds light on drug’s impact on diabetes progression

A Vanderbilt study of a treatment to delay the development of Type 1 diabetes in individuals at high risk did not meet the study goals of delaying progression from normal glucose tolerance to abnormal glucose tolerance or clinical diagnosis, although the study drug, abatacept, impacted immune response and preserved insulin production during the one-year treatment period.

Saunders receives diabetes research innovation award

Vanderbilt’s Diane Saunders, PhD, has been selected as a 2023 recipient of an Innovation Award by the Network of Pancreatic Donors with Diabetes.

Ashcroft named to receive Vanderbilt Prize in Biomedical Science

Professor Dame Frances Ashcroft, a British physiologist known internationally for her work on insulin secretion, Type 2 diabetes and neonatal diabetes, is the recipient of the 2023 Vanderbilt Prize in Biomedical Science.

When half of their six children were diagnosed with what was then believed to be Type 1 diabetes, David and Ellen Pursell decided their family would participate in research related to the health condition. This family photo from several years ago includes, seated, from left, Peggy, Ramsey and Chrissy. Standing, from left, are Vaughan, Ellen, Martin, David and Parker.

Family’s participation key to advancing diabetes research

A study of one family from Alabama has led Vanderbilt researchers to discover that insulin deficiency, independent of the autoimmunity associated with Type 1 diabetes, is the principal factor leading to a markedly smaller pancreas.

Diabetes drug may improve asthma

New biomarker finding strengthens the case for using GLP-1R agonists to treat patients with Type 2 diabetes who also suffer from asthma.

1 2 3 4 14